The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G). Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates, recommendations for resistant infections. Table 5: Recommendations for MDR Bacteria -
Michael S. Saag Book order (chronological)
This author is a distinguished physician and researcher, primarily known for groundbreaking work in infectious diseases, particularly HIV. Their early career involved significant discoveries in the genetic evolution of the virus. This led to the conceptualization and establishment of a pioneering outpatient clinic focused on comprehensive patient care integrated with cutting-edge research and clinical trials. Their extensive contributions include over 320 peer-reviewed articles and numerous textbook chapters, solidifying their position as a leading expert in the field.
The Sanford Guide to Antimicrobial Therapy, 2008 - Thirty-Eighth Edition
- 216 pages
- 8 hours of reading
Annual, pocket-sized, quick reference to antimicrobial information. Includes 20 tables and index. Landscape format.